This trial has completed recruitment on this platform, and is no longer accepting new referrals.
Eli Lilly and Company (the study sponsor) is evaluating the link between patient-reported pain scales and gait (the way that someone walks) as collected from a shoe insole device. While doctors have some options to treat and manage chronic low back and knee pain, many people still do not have adequate pain control and have problems with their daily functioning because of their pain, and more research is needed to better understand this public health problem. This study will enroll 175 adult participants. Some will not have a medical condition, and some will have osteoarthritis or chronic back pain. This trial will last approximately 8 weeks and will not have any drug or medicine involved. The study will be conducted virtually, and participants can complete all study tasks at home.
This study is completely virtual and all study assessments can be conducted at home. There are no clinic visits.
In this study, participants will be screened and enrolled into the study online.
All study activities will be done virtually over approximately 8 weeks.
Eligible participants will be sent all the study kit materials which include a wrist-worn actigraphy device, FeetMe shoe insoles, a smartphone with the FeetMe Research App, and charging cab les for both the insoles and smartphone.
Participants will wear the actigraphy device on the wrist throughout the entire study and will wear the shoe insoles for at least 2 hours every day.
Participants in the study will answer online a daily question on pain level and several brief questionnaires related to pain, physical functioning and sleep every 2 weeks throughout the study. Information collected from these questionnaires, the wrist-worn actigraphy device, and the shoe insole devices may provide new information into the pain condition .